A highly radiopaque vertebroplasty cement using tetraiodinated o-carborane additive

Biomaterials

Volumn 32, Issue 27, 2011, Pages 6389-6398

  Pepiol, Ariadna ^a   Teixidor, Francesc ^a   Saralidze, Ketie ^b   van der Marel, Cees ^c   Willems, Paul ^d   Voss, Laura ^d   Knetsch, Menno L W ^b   Vinas, Clara ^a   Koole, Leo H ^b  

^a INSTITUT DE CIÈNCIA DE MATERIALS DE BARCELONA ICMAB CSIC   (Spain)

^b MAASTRICHT UNIVERSITY   (Netherlands)

^c PHILIPS RESEARCH LABORATORIES   (Netherlands)

^d MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Bone cement; Injectable cement; Radiopacity; Vertebroplasty

Indexed keywords

BIOLOGICAL PROPERTIES; CONTRAST MEASUREMENTS; HIP ARTHROPLASTIES; IN-VITRO; INJECTABLE CEMENT; METHACRYLIC POLYMERS; NEW CEMENTS; PHYSICO-CHEMICALS; POST-IMPLANTATION; RADIOPACITY; RADIOPAQUE MICROSPHERES; STRUCTURAL STABILITIES; VERTEBROPLASTY;

BIOCOMPATIBILITY; BONE; CEMENTS; COMPRESSIVE STRENGTH; INDUSTRIAL CHEMICALS; INFRARED SPECTROSCOPY; IODINE; LEACHING; MATERIALS HANDLING; MECHANICAL PROPERTIES; MICROSPHERES; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PHOTOELECTRON SPECTROSCOPY; SCANNING ELECTRON MICROSCOPY; STABILITY; X RAY PHOTOELECTRON SPECTROSCOPY;

BONE CEMENT;

BARIUM SULFATE; BONE CEMENT; CARBORANE DERIVATIVE; IODINE; METHACRYLIC ACID; MICROSPHERE; TETRAIODOCARBORANE; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; BIOCOMPATIBILITY; BIOLOGICAL ACTIVITY; CONTRAST; CONTROLLED STUDY; IN VITRO STUDY; INFRARED SPECTROSCOPY; MOUSE; NONHUMAN; PERCUTANEOUS VERTEBROPLASTY; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; SCANNING ELECTRON MICROSCOPY; VISCOSITY; X RAY ANALYSIS; X RAY PHOTOELECTRON SPECTROSCOPY;

3T3 CELLS; ANIMALS; BONE CEMENTS; BORON COMPOUNDS; CELL COMMUNICATION; COMPRESSIVE STRENGTH; CONTRAST MEDIA; HUMANS; IODINE; MAGNETIC RESONANCE SPECTROSCOPY; MATERIALS TESTING; METHYLMETHACRYLATE; MICE; MICROSCOPY, ELECTRON, SCANNING; MICROSCOPY, FLUORESCENCE; MICROSPHERES; PARTICLE SIZE; PHOTOELECTRON SPECTROSCOPY; TEMPERATURE; TIME FACTORS; VERTEBROPLASTY;

EID: 79960094774     PISSN: 01429612     EISSN: 18785905     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2011.05.056     Document Type: Article

References (39)

1. Patel N. Percutaneous vertebroplasty: role in treatment of vertebral compression fractures. Phys Med Rehabil Clin N Am 2010, 21:869-876.
2. Hurley M.C., Kaakaji R., Dabus G., Shaibani A., Walker M.T., Fessler R.G., et al. Percutaneous vertebroplasty. Neurosurg Clin N Am 2009, 20:341-359.
3. Eckel T.S., Olan W. Vertebroplasty and vertebral augmentation techniques. Tech Vasc Interv Radiol 2009, 12:44-50.
4. Johnell O., Kanis J.A. An estimate of the worldwide prevalence and disability associated with osteoporotic fractures. Osteoporos Int 2006, 17:1726-1733.
5. Kallmes D.F., Comstock B.A., Heagerty P.J., Turner J.A., Wilson D.J., Diamond T.H., et al. A randomized trial of vertebroplasty for osteoporotic spinal fractures. N Engl J Med 2009, 361:569-579.
6. Buchbinder R., Osborne R.H., Ebeling P.R., Wark D.J., Mitchel P., Graves S., et al. A randomized trial of vertebroplasty for painful osteoporotic vertebral fractures. N Engl J Med 2009, 361:557-568.
7. Klazen C.A., Lohle P.N., de Vries J., Jansen F.H., Tielbeek A.V., Blonk M.C., et al. Vertebroplasty versus conservative treatment in acute osteoporotic vertebral compression fractures (Vertos II): an open-label randomised trial. Lancet 2010, 376:1085-1092.
8. Lewis G., Towler M.R., Boyd D., German M.J., Wren A.W., Clarkin O.M., et al. Evaluation of two novel aluminum-free, zinc-based glass polyalkenoate cements as alternatives to PMMA bone cement for use in vertebroplasty and balloon kyphoplasty. J Mater Sci Mater Med 2010, 59-66.
9. Lewis G., Koole L.H., van Hooy-Corstjens C.S. Influence of powder-to-liquid monomer ratio on properties of an injectable iodine-containing acrylic bone cement for vertebroplasty and balloon kyphoplasty. J Biomed Mater Res B Appl Biomater 2009, 91:537-544.
10. Lewis G. Injectable bone cements for use in vertebroplasty and kyphoplasty: state-of-the-art review. J Biomed Mater Res B Appl Biomater 2006, 76(2):456-468.
11. Carrodeguas R.G., Lasa B.V., Del Barrio J.S. Injectable acrylic bone cements for vertebroplasty with improved properties. J Biomed Mater Res B Appl Biomater 2004, 68:94-104.
12. Pizzoli A.L., Brivio L.R., Caudana R., Vittorini E. Percutaneous CT-guided vertebroplasty in the management of osteoporotic fractures and dorsolumbar metastases. Orthop Clin North Am 2009, 40:449-458.
13. Lee I.J., Choi A.L., Yie M.Y., Yoon J.Y., Jeon E.Y., Koh S.H., et al. CT evaluation of local leakage of bone cement after percutaneous kyphoplasty and vertebroplasty. Acta Radiol 2010, 51:649-654.
14. Krueger A., Bliemel C., Zettl R., Ruchholtz S. Management of pulmonary cement embolism after percutaneous vertebroplasty and kyphoplasty: a systematic review of the literature. Eur Spine J 2009, 18:1257-1265.
15. Jensen M.E., Evans A.J., Mathis J.M., Kallmes D.F., Cloft H.J., Dion J.E. Percutaneous polymethyl methacrylate vertebroplasty in the treatment of osteoporotic vertebral body compression fractures: technical aspects. AJNR Am J Neuroradiol 1997, 18:1897-1904.
16. Venmans A., Klazen C.A., Lohle P.N., van Rooij W.J., Verhaar H.J., de Vries J., et al. Percutaneousvertebroplasty and pulmonary cement embolism: results from VERTOS II. AJNR Am J Neuroradiol 2010, 31:1451-1453.
17. Wang J.S., Diaz J., Sabokbar A., Athanasou N., Kjellson F., Tanner K.E., et al. In vitro and in vivo biological responses to a novel radiopacifying agent for bone cement. J R Soc Interface 2005, 2:71-78.
18. Sabokbar A., Fujikawa Y., Murray D.W., Athanasou N. Radiopaque agents in bone cement increase bone resorption. J Bone Jt Surg Br 1997, 79:129-134.
19. Artola A., Gurruchaga M., Vázquez B., San Román J., Goñi I. Elimination of barium sulphate from acrylic bone cements. Use of two iodine-containing monomers. Biomaterials 2003, 24:4071-4080.
20. Boelen E.J., Lewis G., Xu J., Slots T., Koole L.H., van Hooy-Corstjens C.S. Evaluation of a highly-radiopaque iodine-containing acrylic bone cement for use in augmentation of vertebral compression fractures. J Biomed Mater Res A 2008 Jul, 86(1):76-88.
21. Zaharia C., Zecheru T., Moreau M.F., Pascaretti-Grizon F., Mabilleau G., Marculescu B., et al. Chemical structure of methylmethacrylate-2-[2',3',5'-triiodobenzoyl]oxoethyl methacrylate copolymer, radio-opacity, in vitro and in vivo biocompatibility. Acta Biomater 2008, 4:1762-1769.
22. Vaca A., Teixidor F., Kivekäs R., Sillanpää R., Viñas C. A solvent-free regioselective iodination route of ortho-carboranes. Dalton Trans 2006, 41:4884-4885.
23. Srivastava R.R., Hamlin D.K., Wilbur D.S. Synthesis of highlyiodinatedicosahedral mono- anddicarboncarboranes. J Org Chem 1996, 61:9041-9044.
24. Barberà G., Vaca A., Teixidor F., Sillanpää R., Kivekäs R., Vinas C. Designed synthesis of new orthocarborane derivatives: from mono- to polysubstituted frameworks. Inorg Chem 2008, 47:7309-7316.
25. Teixidor F., Barberà G., Viñas C., Sillanpää R., Kivekäs R. Synthesis of boron-iodinated o-carborane derivatives. Water stability of the periodinatedmonoproticsalt. Inorg Chem 2006, 45:3496-3498.
26. Barth R.F., Coderre J.A., Vicente M.G.H., Blue E.T. Boron neutron capturetherapy:current status andfutureprospects. Clin Cancer Res 2005, 11:3987-4002.
27. Valliant J.F., Guenther K.J., King A.S., Morel P., Schaffer P., Sogbein O.O., et al. The medicinalchemistry of carboranes. CoordChemRev 2002, 232:173-230.
28. Endo Y., Iijima T., Yamakoshi Y., Yamaguchi M., Fukasawa H., Shudo K.J. Potent estrogenicagonistsbearingdicarba-closo-dodecaborane as a hydrophobic-pharmacophore. J Med Chem 1999, 42:1501-1504.
29. Ohta K., Iijima T., Takahashi H., Hashimoto Y., Endo Y. Novelretinoid X receptor (RXR) antagonist having a dicarba-closo-dodecaborane as a hydrophobicmoiety. Bioorg Med Chem Lett 2004, 14:5913-5918.
30. Armstrong A.F., Valliant J.F. The bioinorganic and medicinal chemistry of carboranes: from new drug discovery to molecular imaging and therapy. Dalton Trans 2007, 38:4240-4251.
31. Fujii S., Hashimoto Y., Suzuki T., Ohtac S., Endo Y. A new class of androgen receptor antagonists bearing carborane in place of a steroidal skeleton. Bioorg Med Chem Lett 2005, 15:227-230.
32. Aldenhoff Y.B., Kruft M.A., Pijpers A.P., van der Veen F.H., Bulstra S.K., Koole L.H. Stability of radiopaque iodine-containing biomaterials. Biomaterials 2002, 23:881-886.
33. http://home.megapass.co.kr/%7Edooleekc/tech/cure/TrigonoxC.pdf.
34. Fassina L., Visai L., Asti L., Benazzo F., Speziale P., Tanzi, et al. Calcified matrix production by SAOS-2 cells inside a polyurethane porous scaffold, using a perfusion bioreactor. Tissue Eng 2005, 11:685-700.
35. Poole C.A., Brookes N.H., Gilbert R.T., Beaumont B.W., Crowther A., Scott L., et al. Detection of viable and non-viable cells in connective tissue explants using the fixable fluoroprobes 5-chloromethylfluorescein diacetate and ethidium homodimer-1. Connect Tissue Res 1996, 33:233-241.
36. Stoddart M.J., Furlong P.I., Simpson A., Richards R.G. A comparison of non-reactive methods for assessing viability in ex vivo cultured cancellous bone: technical note. Eur Cell Mater 2006, 12:16-25.
37. " Bone Cements" , Berlin Heidelberg New York 2000, Springer Verlag, p. 142-144.
38. Hermanek S. Boron-11 NMR spectra of boranes, main-group heteroboranes, and substituted derivatives. Factors influencingchemicalshifts of skeletalatoms. Chem Rev 1992, 92:325-362.
39. Tiritiris I., Schleid T., Muller K. Solid-state NMR studies on ionic Closo-dodecaborates. Appl Magn Reson 2007, 32:459-481.